Parkside Financial Bank & Trust’s Iovance Biotherapeutics IOVA Stock Holding History

Parkside Financial Bank & Trust’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.05K	Hold	300	–	–	﹤0.01%	2339
2025 Q4	$819	Buy	+300	New	+$694	﹤0.01%	2408
2025 Q2	–	Sell	-120	Closed	-$400	–	2867
2025 Q1	$400	Buy	+120	New	+$619	﹤0.01%	2541
2022 Q2	–	Sell	-72	Closed	-$2K	–	1877
2022 Q1	$2K	Buy	72 +64	+800%	+$990	﹤0.01%	1610
2021 Q4	$0	Sell	8 -183	-96%	-$4.03K	﹤0.01%	1849
2021 Q3	$5K	Buy	191 +50	+35%	+$1.18K	﹤0.01%	1240
2021 Q2	$4K	Buy	141 +138	+4,600%	+$3.59K	﹤0.01%	1327
2021 Q1	$0	Hold	3	–	–	﹤0.01%	1693
2020 Q4	$0	Hold	3	–	–	﹤0.01%	1637
2020 Q3	$0	Buy	+3	New	+$92	﹤0.01%	1583

Other funds holding IOVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MFM

MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Parkside Financial Bank & Trust's IOVA Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Iovance Biotherapeutics (IOVA) position steady in Q1 2026 at 300 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #2339.

Parkside Financial Bank & Trust first reported a position in IOVA in Q3 2020 and has held it in 10 quarters since. The position peaked at $5K in Q3 2021. 286 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

Parkside Financial Bank & Trust held 300 shares of Iovance Biotherapeutics worth $1.05K as of Q1 2026.
Parkside Financial Bank & Trust left its Iovance Biotherapeutics share count unchanged in Q1 2026.
Iovance Biotherapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2339 holding.
Parkside Financial Bank & Trust first reported a position in Iovance Biotherapeutics in Q3 2020 and has held it in 10 quarters since.
Parkside Financial Bank & Trust's Iovance Biotherapeutics position peaked at $5K in Q3 2021.
286 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.